MedPath

Effect of adding steroids to routine treatment in managing preterm babies with respiratory distress

Not Applicable
Conditions
Health Condition 1: P220- Respiratory distress syndrome of newborn
Registration Number
CTRI/2021/01/030392
Lead Sponsor
Susmitha Tangirala
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All preterm neonates born between 25 weeks and 31 weeks of gestation and requiring surfactant therapy will be included in the study

Exclusion Criteria

Neonates born with major congenital malformations that are incompatible with life will be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath